The investigators analyzed data from about 9600 residents at 196 nursing homes operated by Genesis Health Care in 19 states. The authors compared outcomes in a subset of 1902 residents who received 2 doses of an mRNA vaccine against SARS-CoV-2 and 2 booster doses and a matched set of controls who received the original vaccine series and 1 booster dose.
